Bharat B. Aggarwal is an Indian-American biochemist. His research has been in the areas of cytokines, the role of inflammation in cancer, and the anti-cancer effects of spices and herbs, particularly curcumin (a chemical constituent of the spice turmeric). He was a professor in the Department of Clinical Immunology, Bioimmunotherapy, and Experimental Therapeutics at University of Texas MD Anderson Cancer Center in Houston, Texas. As of 2022, 30 papers published by Aggarwal have been retracted, ten others have received an expression of concern, and 17 others have been corrected.
Attributes | Values |
---|
rdf:type
| |
rdfs:label
| |
rdfs:comment
| - Bharat B. Aggarwal is an Indian-American biochemist. His research has been in the areas of cytokines, the role of inflammation in cancer, and the anti-cancer effects of spices and herbs, particularly curcumin (a chemical constituent of the spice turmeric). He was a professor in the Department of Clinical Immunology, Bioimmunotherapy, and Experimental Therapeutics at University of Texas MD Anderson Cancer Center in Houston, Texas. As of 2022, 30 papers published by Aggarwal have been retracted, ten others have received an expression of concern, and 17 others have been corrected. (en)
|
foaf:name
| |
name
| |
dct:subject
| |
Wikipage page ID
| |
Wikipage revision ID
| |
Link from a Wikipage to another Wikipage
| |
Link from a Wikipage to an external page
| |
sameAs
| |
workplaces
| |
dbp:wikiPageUsesTemplate
| |
alma mater
| |
fields
| |
has abstract
| - Bharat B. Aggarwal is an Indian-American biochemist. His research has been in the areas of cytokines, the role of inflammation in cancer, and the anti-cancer effects of spices and herbs, particularly curcumin (a chemical constituent of the spice turmeric). He was a professor in the Department of Clinical Immunology, Bioimmunotherapy, and Experimental Therapeutics at University of Texas MD Anderson Cancer Center in Houston, Texas. In 2012, MD Anderson launched a review of Aggarwal's research after the federal government notified them of allegations of fraud by academic whistleblowers in as many as 65 of Aggarwal's published papers, with the allegations involving images that had been reused and manipulated to represent different results. He retired at the end of 2015; his departure was not made public until February 2016. As of 2022, 30 papers published by Aggarwal have been retracted, ten others have received an expression of concern, and 17 others have been corrected. (en)
|
institution
| |
gold:hypernym
| |
prov:wasDerivedFrom
| |
page length (characters) of wiki page
| |
academic discipline
| |